*Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

†NewPath Diagnostics, Queens, NY

‡Department of Pathology, Ege University, Izmir, Turkey

∥Department of Pathology, Marmara University, Istanbul, Turkey

#Department of Pathology, Koc University, Istanbul, Turkey

§Department of Pathology, Emory University Hospital, Atlanta, GA

¶Department of Pathology and Clinical Labs, University of Michigan, Ann Arbor, MI

Present address: Aslihan Yavas, MD, Institute of Pathology, Heinrich-Heine University and University Hospital of Dusseldorf, Dusseldorf, Germany.

Present address: David S. Klimstra, MD, Paige AI, New York, NY. Present address: Hulya Sahin Ozkan, MD, Department of Pathology, Marmara University, Istanbul, Turkey.

This study was presented in part at the annual meeting of the United States and Canadian Academy of Pathology in Los Angeles, CA, in March 2020.

Conflicts of Interest and Source of Funding: Funded in part by the Melamed Family Foundation and by the Cancer Center Support Grant of the National Institutes of Health/National Cancer Institute under award number P30CA008748. J.S. is supported in part by the National Cancer Institute of the National Institutes of Health under award number R37CA262209. For the remaining authors, none were declared.

Correspondence: Olca Basturk, MD, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065 (e-mail: [email protected]).

Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's website, www.ajsp.com.